1. Home
  2. AUST vs BOLD Comparison

AUST vs BOLD Comparison

Compare AUST & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUST
  • BOLD
  • Stock Information
  • Founded
  • AUST 2020
  • BOLD 2018
  • Country
  • AUST Canada
  • BOLD United States
  • Employees
  • AUST N/A
  • BOLD N/A
  • Industry
  • AUST
  • BOLD
  • Sector
  • AUST
  • BOLD
  • Exchange
  • AUST Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • AUST 21.1M
  • BOLD 24.4M
  • IPO Year
  • AUST 2022
  • BOLD 2024
  • Fundamental
  • Price
  • AUST $1.81
  • BOLD $1.15
  • Analyst Decision
  • AUST
  • BOLD Buy
  • Analyst Count
  • AUST 0
  • BOLD 4
  • Target Price
  • AUST N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • AUST 136.4K
  • BOLD 77.7K
  • Earning Date
  • AUST 11-05-2025
  • BOLD 11-06-2025
  • Dividend Yield
  • AUST N/A
  • BOLD N/A
  • EPS Growth
  • AUST N/A
  • BOLD N/A
  • EPS
  • AUST N/A
  • BOLD N/A
  • Revenue
  • AUST N/A
  • BOLD N/A
  • Revenue This Year
  • AUST N/A
  • BOLD N/A
  • Revenue Next Year
  • AUST N/A
  • BOLD N/A
  • P/E Ratio
  • AUST N/A
  • BOLD N/A
  • Revenue Growth
  • AUST N/A
  • BOLD N/A
  • 52 Week Low
  • AUST $0.95
  • BOLD $1.00
  • 52 Week High
  • AUST $3.19
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • AUST 65.59
  • BOLD 49.88
  • Support Level
  • AUST $1.72
  • BOLD $1.13
  • Resistance Level
  • AUST $1.95
  • BOLD $1.16
  • Average True Range (ATR)
  • AUST 0.13
  • BOLD 0.04
  • MACD
  • AUST 0.01
  • BOLD 0.00
  • Stochastic Oscillator
  • AUST 75.13
  • BOLD 55.56

About AUST Austin Gold Corp.

Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: